Merck Takes Watson Labs To Court To Protect Fosamax
Merck & Co. is back in court fighting to protect its patent rights to Fosamax, its popular and wildly profitable osteoporosis drug. The drug maker has filed a lawsuit against Watson...To view the full article, register now.
Already a subscriber? Click here to view full article